Follicular Lymphoma: Best Practices in the Therapeutic Management
July 26, 2018
September 26, 2019
Scroll to the Bottom of this Information to Begin this Course
This activity is jointly provided by Postgraduate Institute for Medicine and PlatformQ Health Education, LLC.
This activity is supported by an educational grant from Genentech.
- Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)™
All other health care professionals completing this course will be issued a statement of participation.
This activity is intended for US‐based hematologist‐oncologists, medical oncologists, medical fellows, oncology nurse practitioners, pharmacists, and other health care professionals who treat patients with follicular lymphoma. Other clinicians in radiation oncology, surgery, radiology (including interventional, diagnostic, and nuclear medicine), internal medicine and primary care may also benefit from education.
Upon completion of this activity, participants should be able to:
- Assess optimal time to initiate treatment for FL in order to delay disease progression and maintain patient quality of life
- Appraise evidence‐based guidelines and recommendations regarding first‐line and maintenance therapy for FL
- Evaluate recent safety and efficacy clinical trial data for the therapeutic management of previously untreated FL
Jonathan W. Friedberg, MD, MMSc
Samuel E. Durand Professor of Medicine
Director, Wilmot Cancer Institute
University of Rochester
John P. Leonard, MD
Richard T. Silver Distinguished Professor of Hematology and Medical Oncology
Associate Dean for Clinical Research
Associate Director, Sandra and Edward Meyer Cancer Center
Executive Vice Chair, Joan and Sanford I. Weill Department of Medicine
Weill Cornell Medicine
Thomas E. Witzig, MD
Professor of Medicine
Division of Hematology, Department of Medicine
Mayo Clinic in Rochester, Minnesota
Physician Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and PlatformQ Health Education, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Credit Designation
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures of Conflicts of Interest
Jonathan W. Friedberg MD, MMsc
- Consulting Fees: Astellas, Bayer
John P. Leonard, MD
- Consulting Fees: ADC Therapeutics, AstraZeneca, Celgene, Bayer, Biotest, BMS, Gilead, Genentech, Juno, Karyopharm, MEI Pharma, Novartis, Pfizer, Rohe, Sutro, United Therapeutics
Thomas E. Witzig, MD
- Consulting Fees: Sandoz
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Anne Roc, PhD
The PIM planners and managers have nothing to disclose.
The following PlatformQ Health Education, LLC planner, Alissa Yost, hereby states that she or her spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Instructions for Participation and Credit
There are no fees to participate in this activity. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credits™, participants must receive a minimum score of 70% on the post-test.
COURSE VIEWING REQUIREMENTS
Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Accreditation Support: Please contact the Postgraduate Institute for Medicine at www.pimed.com.
Technical Support: For any technical issues or issues with your CME Certificate, please contact OMedLive at 877-394-1306 or at Support@OMedLive.com.
Information we collect is primarily used to communicate with program participants, award CME/CE credits, manage user accounts, recommend relevant programs and perform data analysis to inform educational outcomes.
In plain English, here is what we affirm:
- You can change your registration profile at any time from our “Profile” page
- To request any of these changes without logging in, please call us at 1 (877) 394-1306 or email us at support@PlatformQHealth.com
- You can end your association with PlatformQ Health at any time
- PlatformQ Health does not spam, nor we do we rent or sell our email list in whole or in part. Any program-related data sharing is for engagement verification and opt-in based further education
- EU citizens can request a complete record of their account and/or request to have their personal data expunged by contacting email@example.com with the subject line “Data Request”